MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CNMD — CONMED Corporation
NYSECONMED Corporation
$46.32
+0.39(+0.85%)
- O
- 46.88
- H
- 47.06
- L
- 46.16
- V
- 240.73K
⏱️ End-of-day dataAs of Oct 2, 2026
CONMED Corporation Statistics
Total Valuation
| Market Cap | $1.36B |
| Enterprise Value | $1.36B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | 2025-09-15 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | 29.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | 102.93 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1,544.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 128,467.64 |
| P/OCF Ratio | 35,266.02 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 98,352.09 |
| EV / Sales | n/a |
| EV / EBITDA | 30,733.36 |
| EV / EBIT | 53,512.21 |
| EV / FCF | 128,545.63 |
Financial Position
| Current Ratio | 2.29 |
| Quick Ratio | n/a |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 19.44 |
| Debt / FCF | 81.30 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | 1.36% |
| Return on Assets (ROA) | 0.60% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $4 |
| Employee Count | 3,900 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | $4.53K |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -0.60% |
| 50-Day Moving Average | $47.91 |
| 200-Day Moving Average | $40.91 |
| Relative Strength Index (RSI) | 49.63 |
| Average Volume (20 Days) | 335,354 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | $183.45K |
| Operating Income | $25.41K |
| Pretax Income | $18.36K |
| Net Income | $13.83K |
| EBITDA | $44.25K |
| EBIT | $25.41K |
| Earnings Per Share | $0.45 |
Balance Sheet
| Cash & Cash Equivalents | $35.03K |
| Total Debt | $860.16K |
| Net Cash | -$825.13K |
| Net Cash Per Share | $-0.03 |
| Equity (Book Value) | $1.02M |
| Book Value Per Share | $0.03 |
| Working Capital | $377.88K |
Cash Flow
| Operating Cash Flow | $38.54K |
| Capital Expenditures | -$2.89K |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | $10.58K |
| FCF Per Share | $0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
| Dividend Per Share | $0.80 |
| Dividend Yield | 1.73% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.97% |
| FCF Yield | 0.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
| Lynch Fair Value | $6.75 |
| Lynch Upside | -85.43% |
| Graham Number | $0.55 |
| Graham Upside | -98.81% |
Stock Splits
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |